Worth Seeing!
Stock Screener - Find opportunities by screening stocks in unique ways Find Now Find Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 74005.94
88.91 (0.12%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Kopran Ltd.
1,202
(Small Cap)
249.80
(-0.89%)
34.21
2.96
12.18
217.28
Unlock
2
Gujarat Themis Biosyn Ltd.
2,978
(Small Cap)
412.95
(2.20%)
49.7
14.6
30.87
72.01
Unlock
3
Supriya Lifescience Ltd.
3,068
(Small Cap)
382.55
(1.58%)
25.22
3.88
16.71
67.00
Unlock
4
Narayana Hrudayalaya Ltd.
26,416
(Small Cap)
1,295.35
(0.19%)
33.45
9.6
14.68
62.83
Unlock
5
Marksans Pharma Ltd.
7,559
(Small Cap)
166.90
(-1.33%)
63.02
6.28
17.33
59.01
Unlock
6
Neuland Laboratories Ltd.
7,991
(Small Cap)
6,228.75
(-0.42%)
26.65
6.26
17.70
56.85
Unlock
7
Global Health Ltd.
37,747
(Mid Cap)
1,409.10
(-0.76%)
106.93
13.56
7.84
44.84
Unlock
8
Rainbow Childrens Medicare Ltd.
14,147
(Small Cap)
1,389
(3.64%)
62.1
11.12
22.62
38.74
Unlock
9
Laurus Labs Ltd.
23,957
(Small Cap)
443.65
(0.84%)
148.63
5.8
24.05
38.61
Unlock
10
RPG Life Sciences Ltd.
2,485
(Small Cap)
1,501.40
(-0.80%)
28.29
6.62
8.32
38.58
Unlock
11
Astrazeneca Pharma India Ltd.
14,393
(Small Cap)
5,757.35
(-0.01%)
101.21
21.02
11.93
36.87
Unlock
12
Procter & Gamble Health Ltd.
7,993
(Small Cap)
4,815.05
(0.56%)
36.95
9.28
11.99
36.80
Unlock
13
Dr. Reddys Laboratories Ltd.
97,001
(Large Cap)
5,812.50
(0.23%)
17.47
3.45
11.55
36.08
Unlock
14
Apollo Hospitals Enterprise Ltd.
85,652
(Large Cap)
5,955.60
(0.06%)
85.41
11.29
-1.90
34.75
Unlock
15
Gufic Biosciences Ltd.
3,446
(Small Cap)
345.90
(0.30%)
39.84
6.54
17.71
34.15
Unlock
16
Themis Medicare Ltd.
1,969
(Small Cap)
213.95
(1.74%)
76.3
7.05
11.08
34.06
Unlock
17
AMI Organics Ltd.
4,584
(Small Cap)
1,240.20
(-0.76%)
103.86
6.72
26.79
33.72
Unlock
18
Sigachi Industries Ltd.
2,268
(Small Cap)
69.11
(5.00%)
55.78
5.06
23.28
32.58
Unlock
19
KMC Speciality Hospitals (India) Ltd.
1,452
(Small Cap)
89.05
(-0.26%)
N/A
N/A
17.12
31.95
Unlock
20
JB Chemicals & Pharmaceuticals Ltd.
28,566
(Small Cap)
1,835
(0.61%)
56.18
10.11
18.11
31.92
Unlock
21
Biocon Ltd.
36,582
(Mid Cap)
304.95
(-0.29%)
19.17
3.38
-3.80
31.80
Unlock
22
Granules India Ltd.
9,856
(Small Cap)
405.50
(0.92%)
22.23
3.12
19.01
31.51
Unlock
23
Indraprastha Medical Corporation Ltd.
2,406
(Small Cap)
262
(-0.59%)
19.99
5.07
7.86
31.45
Unlock
24
Krsnaa Diagnostics Ltd.
1,936
(Small Cap)
595.40
(-0.33%)
37.23
2.5
38.65
29.24
Unlock
25
Indoco Remedies Ltd.
2,970
(Small Cap)
321.05
(0.42%)
25.28
2.71
9.93
28.74
Unlock
26
Jupiter Life Line Hospitals Ltd.
8,157
(Small Cap)
1,239.45
(-0.43%)
53.38
6.51
19.71
26.72
Unlock
27
Sun Pharmaceutical Industries Ltd.
3,67,290
(Large Cap)
1,532.85
(0.08%)
41.39
5.91
10.69
26.54
Unlock
28
Bajaj Healthcare Ltd.
843
(Small Cap)
304
(-0.62%)
40.17
2.66
18.39
25.96
Unlock
29
Alembic Pharmaceuticals Ltd.
19,001
(Small Cap)
965.05
(0.52%)
30.95
3.96
12.54
23.14
Unlock
30
Vimta Labs Ltd.
1,111
(Small Cap)
501
(1.40%)
28.17
3.64
11.43
22.79
Unlock
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Sigachi Industries
69.115%
Zydus Lifesciences
1,104.455%
Concord Biotech
1,493.904.36%
RainbowChildrenS Med
1,3893.64%
Aurobindo Pharma
1,203.903.44%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Shilpa Medicare
499.30-4.38%
Caplin Point Lab
1,313.05-1.90%
HealthcareGlobal
359.15-1.41%
Marksans Pharma
166.90-1.33%
Gland Pharma
1,768.35-1.31%
View More

News about Top Pharma Companies in India

Vimta Labs - Quaterly Results

The revenue slipped marginally during the March 2024 quarter. A decline of about Rs. 783.38 millions was observed as compared to Rs. 808.03 millions during the corresponding quarter last year.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 118.01  millions as against Rs. 122.50 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 241.11 millions from 242.24 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 783.38 808.03 -3.05 3128.91 3151.16 -0.71 3128.91 3151.16 -0.71
Other Income 4.87 6.65 -26.77 40.10 34.68 15.63 40.10 34.68 15.63
PBIDT 241.11 242.24 -0.47 876.49 970.15 -9.65 876.49 970.15 -9.65
Interest 5.28 2.48 112.90 21.13 26.44 -20.08 21.13 26.44 -20.08
PBDT 235.83 239.76 -1.64 855.36 943.71 -9.36 855.36 943.71 -9.36
Depreciation 80.32 79.98 0.43 339.99 305.40 11.33 339.99 305.40 11.33
PBT 155.51 159.78 -2.67 515.37 638.31 -19.26 515.37 638.31 -19.26
TAX 37.50 37.28 0.59 127.30 165.32 -23.00 127.30 165.32 -23.00
Deferred Tax -9.30 -0.18 5066.67 -34.09 -22.37 52.39 -34.09 -22.37 52.39
PAT 118.01 122.50 -3.67 388.07 472.99 -17.95 388.07 472.99 -17.95
Equity 44.34 44.26 0.18 44.34 44.26 0.18 44.34 44.26 0.18
PBIDTM(%) 30.78 29.98 2.67 28.01 30.79 -9.01 28.01 30.79 -9.01
18 May, 2024

Global Health informs about investor presentation

Global Health has informed that it enclosed the copy of Investor Presentation, for the Quarter and Financial Year ended March 31, 2024 Results of the Company.

The above information is a part of company’s filings submitted to BSE.

18 May, 2024

JB Chem & Pharma - Quaterly Results

A fair growth of 15.74% in the revenue at Rs. 8092.00 millions was reported in the March 2024 quarter as compared to Rs. 6991.40 millions during year-ago period.A comparatively good net profit growth of 41.93% to Rs. 1258.50 millions was reported for the quarter ended March 2024 compared to Rs. 886.70 millions of previous same quarter.Operating profit surged to 2111.50 millions from the corresponding previous quarter of 1647.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 8092.00 6991.40 15.74 32986.40 28841.60 14.37 32986.40 28841.60 14.37
Other Income 161.00 33.00 387.88 346.80 86.50 300.92 346.80 86.50 300.92
PBIDT 2111.50 1647.40 28.17 9141.00 6733.40 35.76 9141.00 6733.40 35.76
Interest 83.20 122.60 -32.14 405.20 343.10 18.10 405.20 343.10 18.10
PBDT 2028.30 1524.80 33.02 8735.80 6390.30 36.70 8735.80 6390.30 36.70
Depreciation 397.20 305.60 29.97 1352.40 1119.90 20.76 1352.40 1119.90 20.76
PBT 1631.10 1219.20 33.78 7383.40 5270.40 40.09 7383.40 5270.40 40.09
TAX 372.60 332.50 12.06 1949.80 1381.50 41.14 1949.80 1381.50 41.14
Deferred Tax 93.40 109.00 -14.31 494.90 548.00 -9.69 494.90 548.00 -9.69
PAT 1258.50 886.70 41.93 5433.60 3888.90 39.72 5433.60 3888.90 39.72
Equity 155.20 154.80 0.26 155.20 154.80 0.26 155.20 154.80 0.26
PBIDTM(%) 26.09 23.56 10.74 27.71 23.35 18.70 27.71 23.35 18.70
17 May, 2024

Ami Organics informs about earnings call transcript

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ami Organics has enclosed the transcript of the Earnings conference call held on May 13, 2024 post announcement of financial results for the fourth quarter and year ended on March 31, 2024. The same will also be available at the website of Company at www.amiorganics.com

The above information is a part of company’s filings submitted to BSE.
17 May, 2024

Global Health - Quaterly Results

The revenue for the March 2024 quarter is pegged at Rs. 5786.45 millions, about 14.32% up against Rs. 5061.58 millions recorded during the year-ago period.A humble growth in net profit of 13.93% reported in the quarter ended March 2024 to Rs. 922.36  millions from Rs. 809.55 millions.Operating profit for the quarter ended March 2024 rose to 1547.66 millions as compared to 1309.27 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5786.45 5061.58 14.32 22800.08 19735.37 15.53 22800.08 19735.37 15.53
Other Income 325.47 248.54 30.95 1028.68 475.92 116.15 1028.68 475.92 116.15
PBIDT 1547.66 1309.27 18.21 6002.18 4639.56 29.37 6002.18 4639.56 29.37
Interest 62.11 63.79 -2.63 244.57 261.61 -6.51 244.57 261.61 -6.51
PBDT 1485.55 1245.48 19.28 5757.61 4377.95 31.51 5757.61 4377.95 31.51
Depreciation 233.90 203.54 14.92 870.90 860.88 1.16 870.90 860.88 1.16
PBT 1251.65 1041.94 20.13 4886.71 3517.07 38.94 4886.71 3517.07 38.94
TAX 329.29 232.39 41.70 1277.80 884.60 44.45 1277.80 884.60 44.45
Deferred Tax -12.97 9.49 -236.67 -117.95 -89.02 32.50 -117.95 -89.02 32.50
PAT 922.36 809.55 13.93 3608.91 2632.47 37.09 3608.91 2632.47 37.09
Equity 537.01 536.39 0.12 537.01 536.39 0.12 537.01 536.39 0.12
PBIDTM(%) 26.75 25.87 3.40 26.33 23.51 11.98 26.33 23.51 11.98
17 May, 2024

Global Health - Quaterly Results

A fair growth of 14.32% in the revenue at Rs. 5786.45 millions was reported in the March 2024 quarter as compared to Rs. 5061.58 millions during year-ago period.Profit saw a slight increase of 13.93%to Rs. 922.36  millions from Rs. 809.55 millions.Operating profit surged to 1547.66 millions from the corresponding previous quarter of 1309.27 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5786.45 5061.58 14.32 22800.08 19735.37 15.53 22800.08 19735.37 15.53
Other Income 325.47 248.54 30.95 1028.68 475.92 116.15 1028.68 475.92 116.15
PBIDT 1547.66 1309.27 18.21 6002.18 4639.56 29.37 6002.18 4639.56 29.37
Interest 62.11 63.79 -2.63 244.57 261.61 -6.51 244.57 261.61 -6.51
PBDT 1485.55 1245.48 19.28 5757.61 4377.95 31.51 5757.61 4377.95 31.51
Depreciation 233.90 203.54 14.92 870.90 860.88 1.16 870.90 860.88 1.16
PBT 1251.65 1041.94 20.13 4886.71 3517.07 38.94 4886.71 3517.07 38.94
TAX 329.29 232.39 41.70 1277.80 884.60 44.45 1277.80 884.60 44.45
Deferred Tax -12.97 9.49 -236.67 -117.95 -89.02 32.50 -117.95 -89.02 32.50
PAT 922.36 809.55 13.93 3608.91 2632.47 37.09 3608.91 2632.47 37.09
Equity 537.01 536.39 0.12 537.01 536.39 0.12 537.01 536.39 0.12
PBIDTM(%) 26.75 25.87 3.40 26.33 23.51 11.98 26.33 23.51 11.98
17 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Kopran Ltd. 1,202 Crore
2 Gujarat Themis Biosyn Ltd. 2,978 Crore
3 Supriya Lifescience Ltd. 3,068 Crore
4 Narayana Hrudayalaya Ltd. 26,416 Crore
5 Marksans Pharma Ltd. 7,559 Crore
6 Neuland Laboratories Ltd. 7,991 Crore
7 Global Health Ltd. 37,747 Crore
8 Rainbow Childrens Medicare Ltd. 14,147 Crore
9 Laurus Labs Ltd. 23,957 Crore
10 RPG Life Sciences Ltd. 2,485 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,821 20,331 37.01 18.76 23.75 51.69
Abbott India Ltd. (M) Very Good 26,618 56,616 47.13 15.31 32.02 31.69
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 97,001 17.39 3.43 10.98 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,699 91,556 61.28 12.80 29.38 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Zydus Lifesciences Ltd. (L) Very Good 1,104 1,11,134 117.7
Lupin Ltd. (M) Somewhat Good 1,662 75,652 113.0
Aurobindo Pharma Ltd. (M) Very Good 1,204 70,468 100.7
Ipca Laboratories Ltd. (M) Very Good 1,311 33,258 94.25
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 82.76
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 24.05
Granules India Ltd. (S) Somewhat Good 405.5 9,856 22.61 3.17 13.23 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 52.57 9.90 31.56 18.11
Gland Pharma Ltd. (M) Very Good 1,768 29,304 36.58 3.38 20.84 17.42
Mankind Pharma Ltd. (L) Very Good 2,115 84,596 46.39 8.79 32.35 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 97,001 17.39 3.43 10.98 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 52.57 9.90 31.56 31.92
Biocon Ltd. (M) Somewhat Good 304.9 36,582 306.6 3.35 83.47 31.80
Granules India Ltd. (S) Somewhat Good 405.5 9,856 22.61 3.17 13.23 31.51
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.